Table 14. Effect of GBTSs on Proliferation Rates of Thymocyte in Vitro.
Concentration (mg/㎖) | Proliferation rates (%) |
GBT (mg/㎖) | GBTG (mg/㎖) | GBTJ (mg/㎖) |
con(-) | 100.0±13.1 | 100.0±11.2 | 100.0±19.9 |
con(+) | 126.8±11.4 | 127.9±10.7 | 115.9±7.1 |
0.01 | 141.2±13.8 | 116.9±8.4 | 108.6±12.1 |
0.02 | 119.5±16.2 | 114.6±14.2 | 106.4±11.9 |
0.03 | 118.7±17.5 | 123.7±11.7 | 100.7±18.5 |
0.06 | 118.4±6.4 | 110.7±14.3 | 91.5±20.4 |
0.13 | 113.3±13.0 | 99.3±6.2* | 109.1±13.0 |
0.25 | 107.0±7.8 | 88.1±8.9** | 110.8±13.0 |
0.50 | 112.8±15.7 | 94.6±6.2** | 107.2±17.1 |
1.00 | 124.7±6.10 | 105.7±5.9** | 94.6±11.8* |
Con(-): GBTSs and LPS not treated group, Con(+): GBTSs not treated and LPS treated group, GBT: BTS except talcum, GBTG: GBT added Lonicerae Japonicae Flos, GPTJ: GBT added Kochiae Fructus. Values are represented as mean±SD. *: Indicates significant difference from control(+) group(*P<0.05). **: Indicates significant difference from control(+) group(**P<0.01).